JP2000503764A - 増殖性動脈疾患の診断および治療におけるrc―9の使用 - Google Patents
増殖性動脈疾患の診断および治療におけるrc―9の使用Info
- Publication number
- JP2000503764A JP2000503764A JP09522889A JP52288996A JP2000503764A JP 2000503764 A JP2000503764 A JP 2000503764A JP 09522889 A JP09522889 A JP 09522889A JP 52288996 A JP52288996 A JP 52288996A JP 2000503764 A JP2000503764 A JP 2000503764A
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- sequence
- seq
- protein
- dna sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US880195P | 1995-12-18 | 1995-12-18 | |
| US60/008,801 | 1995-12-18 | ||
| PCT/US1996/019671 WO1997022880A1 (en) | 1995-12-18 | 1996-12-13 | Use of rc-9 in diagnosis and treatment of proliferative arterial disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2000503764A true JP2000503764A (ja) | 2000-03-28 |
Family
ID=21733759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP09522889A Pending JP2000503764A (ja) | 1995-12-18 | 1996-12-13 | 増殖性動脈疾患の診断および治療におけるrc―9の使用 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0904543A1 (de) |
| JP (1) | JP2000503764A (de) |
| AU (1) | AU1413997A (de) |
| WO (1) | WO1997022880A1 (de) |
| ZA (1) | ZA9610584B (de) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010018870A1 (ja) | 2008-08-15 | 2010-02-18 | 藤倉化成株式会社 | 動脈硬化診断用ポリペプチドマーカー、及び該マーカー等を用いる動脈硬化の検出方法、並びに動脈硬化診断用キット |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0879883A1 (de) * | 1997-05-22 | 1998-11-25 | Smithkline Beecham Corporation | ATG-1120 (AIF-1-DELTA), eine Spleissvariante von AIF-1/RC-9 |
| EP0879882A1 (de) * | 1997-05-22 | 1998-11-25 | Smithkline Beecham Corporation | ATG-1100 (AIF-Gamma), eine Spleissvariante von AIF-1/RC-9 |
| WO2002062839A2 (en) * | 2001-02-07 | 2002-08-15 | Universiteit Maastricht | Markers of unstable atherosclerotic plaques |
-
1996
- 1996-12-13 JP JP09522889A patent/JP2000503764A/ja active Pending
- 1996-12-13 WO PCT/US1996/019671 patent/WO1997022880A1/en not_active Ceased
- 1996-12-13 EP EP96944297A patent/EP0904543A1/de not_active Withdrawn
- 1996-12-13 AU AU14139/97A patent/AU1413997A/en not_active Abandoned
- 1996-12-17 ZA ZA9610584A patent/ZA9610584B/xx unknown
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010018870A1 (ja) | 2008-08-15 | 2010-02-18 | 藤倉化成株式会社 | 動脈硬化診断用ポリペプチドマーカー、及び該マーカー等を用いる動脈硬化の検出方法、並びに動脈硬化診断用キット |
| EP3021121A1 (de) | 2008-08-15 | 2016-05-18 | Fujikura Kasei Co., Ltd. | Polypeptidmarker zur diagnose von arteriosklerose, verfahren für den nachweis von arteriosklerose anhand des markers oder dergleichen und kit für die diagnose von arteriosklerose |
| US9366681B2 (en) | 2008-08-15 | 2016-06-14 | Fujikura Kasei Co., Ltd. | Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis |
Also Published As
| Publication number | Publication date |
|---|---|
| AU1413997A (en) | 1997-07-14 |
| EP0904543A1 (de) | 1999-03-31 |
| ZA9610584B (en) | 1997-06-23 |
| WO1997022880A1 (en) | 1997-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69933998T2 (de) | Verbindungen und verfahren für therapie und diagnose von lungenkrebs | |
| DE69531892T2 (de) | Fibroblasten-wachstumsfaktor 10 | |
| US6322976B1 (en) | Compositions and methods of disease diagnosis and therapy | |
| WO1996026215A1 (en) | Ingap protein involved in pancreatic islet neogenesis | |
| JP4111539B2 (ja) | 膵島新生に関与するingapタンパク質 | |
| US6368794B1 (en) | Detection of altered expression of genes regulating cell proliferation | |
| JP2000503764A (ja) | 増殖性動脈疾患の診断および治療におけるrc―9の使用 | |
| AU645243B2 (en) | Human heat shock factor | |
| US6537794B1 (en) | Chemokine | |
| US6090580A (en) | Interferon responsive transcript (IRT-1) | |
| WO2000046372A2 (en) | Pancreatic islet genes regulated by glucose | |
| US20030104418A1 (en) | Diagnostic markers for breast cancer | |
| AU708499C (en) | Ingap protein involved in pancreatic islet neogenesis | |
| JP2001352991A (ja) | βアミロイド蛋白質により発現誘導される新規遺伝子 | |
| AU5731500A (en) | Gene expression modulated in gastrointestinal inflammation | |
| JP2001258575A (ja) | βアミロイドにより誘導できる遺伝子 | |
| WO1998033890A1 (en) | Human regeneration-associated serpin-1 (rasp-1) and methods of use | |
| JPH1132783A (ja) | Hfizg53ポリヌクレオチドおよびポリペプチド | |
| JPH05219959A (ja) | 新規なdnaおよびそれによってコードされる蛋白質 | |
| MXPA96003897A (en) | Factor 10 of fibroblas growth | |
| JPH119287A (ja) | Atg−1117(aif−3)、同種異型移植炎症性因子−1/rc−9の新規相同物 | |
| JP2002247983A (ja) | ヒト血管ibp様成長因子 | |
| AU2001232958A1 (en) | Modulation of gene expression in formation of fatty atherosclerotic lesions |